Medidata’s Second Annual AI Report Shows a Shift from Pilots to Enterprise Adoption with 72.9% of Early Adopters Seeing a Reduction in Study Timelines

While 92% of respondents plan to increase AI investment, early adopters have a big advantage across nearly all key metrics NEW YORK, May 18, 2026 (GLOBE NEWSWIRE) — Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today released its second annual report on the state of... The post Medidata’s Second Annual AI Report Shows a Shift from Pilots to Enterprise Adoption with 72.9% of Early Adopters Seeing a Reduction in Study Timelines appeared first on Montreal Gazette .

Original source: Montreal Gazette